Company Profiles

driven by the PitchBook Platform

Airway Therapeutics

Description

Developer of acute and chronic lung disease therapies created to redefine protein therapeutics development for pediatrics. The company's lead product, AT-100, is a recombinant form of human surfactant protein-D, absent from current therapies, that changes the properties of the commercial lung surfactant, converting it to a more natural state in the lungs so the body can better use it, thus improving lung function.

2011

Founded

PRIVATE

Status

Early Stage VC

Latest Deal Type

$6.3M

Latest Deal Amount

$12.1M

Total Amount Raised

4

Investors

Description

Developer of acute and chronic lung disease therapies created to redefine protein therapeutics development for pediatrics. The company's lead product, AT-100, is a recombinant form of human surfactant protein-D, absent from current therapies, that changes the properties of the commercial lung surfactant, converting it to a more natural state in the lungs so the body can better use it, thus improving lung function.

Website:

www.airwaytherapeutics.com

Ownership Status

Privately Held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Other Industries

Drug Discovery

Primary Office

11804 Conrey Road Suite 175 Cincinnati, OH 45249United States +1 (513) 770-9630
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Airway Therapeutics's full profile, request a free trial.

    Airway Therapeutics Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Airway Therapeutics Investors (4)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    Cincinnati Children's Hospital Medical CenterNot-For-Profit Venture CapitalMinority000 0000000 0000
    CincyTechVenture CapitalMinority000 0000000 0000
    KTECH CapitalVenture CapitalMinority000 0000000 0000
    Queen City AngelsAngel GroupMinority000 0000000 0000
    Cincinnati Children's Hospital Medical Center Not-For-Profit Venture Capital
    CincyTech Venture Capital
    KTECH Capital Venture Capital
    Queen City Angels Angel Group

    Airway Therapeutics Executive Team (4)

    NameTitleBoard
    Seat
    Contact
    Info
    Marc Salzberg MDChief Executive Officer, President & Board Member
    Andrew LevyChief Financial Officer
    Jan Rosenbaum Ph.DChief Scientific Officer
    Paul RemsenVice President of Manufacturing
    Marc Salzberg MD Chief Executive Officer, President & Board Member
    Andrew Levy Chief Financial Officer
    Jan Rosenbaum Ph.D Chief Scientific Officer
    Paul Remsen Vice President of Manufacturing

    Airway Therapeutics Board Members (5)

    NameRepresentingRoleSinceContact
    Info
    Jennifer DauerCincyTechBoard Member000 0000
    John Rice Ph.DCincyTechDirector of Life Sciences000 0000
    Marc Salzberg MDAirway TherapeuticsChief Executive Officer, President & Board Member000 0000
    Michael VenerableCincyTechPresident000 0000
    Nicole Robinson Ph.DSelfBoard Member000 0000
    Jennifer Dauer Board Member CincyTech
    John Rice Ph.D Director of Life Sciences CincyTech
    Marc Salzberg MD Chief Executive Officer, President & Board Member Airway Therapeutics
    Michael Venerable President CincyTech
    Nicole Robinson Ph.D Board Member Self
    Request full access to PitchBook